Approval · Notice of Compliance 28226 · 2022
ZONOVATE: Notice of Compliance 28226
Issued May 19, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28226
- Date
- May 19, 2022
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug product manufacturing sitE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZONOVATE | Not yet assigned | — |
Medicinal ingredients
- TUROCTOCOG ALFA 250 UNIT per VIAL
- TUROCTOCOG ALFA 500 UNIT per VIAL
- TUROCTOCOG ALFA 1,000 UNIT per VIAL
- TUROCTOCOG ALFA 1,500 UNIT per VIAL
- TUROCTOCOG ALFA 2,000 UNIT per VIAL
- TUROCTOCOG ALFA 3,000 UNIT per VIAL